Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981 (ii): 1129–1133.
Lai M, Chen P, Yang P, Sheu J, Shung J, Chen D. Identification and characterization of intrahepatic Hepatitis B virus DNA in HBsAg seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 1990; 12: 575–581.
Takada S, Gotoh Y, Hayashi Sh, Kobayasi M, Koike K. Integrated structures of HBV DNA in chronic hepatitis and hepatoma tissues. Gastroenterol Japon 1990; 25: 33–37.
Kekulé AS, Lauer U, Meyer M, Caselmann W, Hofschneider PH, Koshy R. The PreS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990; 343: 457–461.
Takada S, Koike K. Transactivation function of a 3′ truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. Proc Natl Acad Sci USA 1990; 87: 5628–5632.
Fourel G, Trepo C, Bougesleret L, et al. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumors. Nature 1990; 347: 294–298.
Hsu T, Fourel G, Etiemble J, Tiollais P, Buendia M-A. Integration of hepatitis virus DNA near c-myc in woodchuck hepatocellular carcinoma. Gastroenterol Japon 1990; 25: 43–48.
Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, et al. Polymerase chain reaction to detect hepatits B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Eng J Med 1990; 323: 80–85.
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989; 244: 359–362.
Esteban JI, Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989 (ii): 294–297.
Roggendorf M, Deinhardt F, Rasshofer R, et al. Antibodies to hepatitis C virus. Lancet 1989 (ii): 324–325.
Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989 (ii): 1004–1006.
Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies of hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989 (ii): 1006–1008.
Farinati F, Fagiuoli S, De Maria N, et al. Anti-HCV positive hepatocellular carcinoma in cirrhosis. J Hepatol 1992; 14: 183–187.
Hasan F, Jeffers L, De Medina M, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12: 589–591.
Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335: 873–874.
Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to Hepatitis C Virus. Hepatology 1990; 12: 671–675.
Lee S, Lee F, Wu J, Hwang S, Wang S, Lo K. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer 1990; 69: 342–345.
Nishioka K, Watanabe J, Furuta S, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429–433.
Ohkoshi S, Kojima H, Tawaraya H, et al. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 550–553.
Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547–6549.
Tzonou A, Trichopoulos D, Kaklamani K, Zavitsanos X, Koumantaki Y, Hsieh C. Epidemiologic assessment of interactions of hepatitis-C virus with seromarkers of hepatitis-B and -D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma. Int J Cancer 1991; 49: 377–380.
Yu M, Tong M, Coursaget P, Ross R, Govindarajan S, Henderson E. Prevalence of Hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Nat Cancer Ins 1990; 82 (12): 1038–1041.
Fuchs K, Motz M, Schreier E, Zachoval R, Deinhart F, Roggendorf M. Characterization of nucleotide sequences from European hepatitis C virus isolates. Gene 1991; 103: 163–169.
Okamoto H, Okada S, Sugiyama Y, et al. The 5′-terminal sequence of hepatitis C virus genome. Japan J Exp Med 1990; 60: 167–177.
Zaaijer HL, Cuypers HTM, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722–724.
Valenzuela P, Quiroga M, Zaldivar J, et al. The nucleotide sequence of the hepatitis B viral genome and the identification of the major viral genes. In: Fields BN, Jaenichs R, Fox CF, eds. Animal virus genetics. New York: Academic Press, 1980: 55–70.
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463–5467.
Domenech JM. Bioestadística. Métodos estadísticos para investigadores, 3rd ed. Barcelona: Ed. Herder, 1980.
Cristiano K, DiBisceglie AM, Hoofnagle JM, Feinstone SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: Detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991; 14: 51–55.
Farci P, Alter HJ, Wong D, et al. A long term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325: 98–104.
Brillanti S, Barbara L, Miglioli M, Bonino F. Hepatitis C virus: A possible cause of chronic hepatitis in alcoholics. Lancet 1989 (ii): 1390–1391.
Ruíz J, Sangro B, Cuendo JI, et al. Hepatitis B and C viral infection in patients with hepatocellular carcinoma. Hepatology 1992; 16: 637–641.